Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ardizzoni, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Porta, C.; Ardizzoni, A.; Gaudino, G.
      Malignant mesothelioma in 2004: how advanced technology and new drugs are changing the oerspectives of mesothelioma patients. Highlights from the VII meeting of the International Mesothelioma Interest Group

      Medicina del lavoro
    2. Ardizzoni, A
      Osteocyte lacunar size-lamellar thickness relationships in human secondaryosteons

      BONE
    3. Grossi, F; Scolaro, T; Tixi, L; Loprevite, M; Ardizzoni, A
      The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    4. Tjan-Heijnen, VCG; Postmus, PE; Ardizzoni, A; Manegold, C; Burghouts, J; van Meerbeeck, J; Gans, S; Mollers, M; Buchholz, E; Biesma, B; Legrand, C; Debruyne, C; Giaccone, G
      Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

      ANNALS OF ONCOLOGY
    5. Scolaro, T; Bacigalupo, A; Ardizzoni, A; Tixi, L; Cafferata, M; Grossi, F; Rosso, R; Vitale, V
      Acute effects in patients with inoperable NSCLC treated by a regimen of induction chemotherapy (CT) followed by radiotherapy (RT) and concurrent CT

      TUMORI
    6. Loprevite, M; Favoni, RE; de Cupis, A; Pirani, P; Pietra, G; Bruno, S; Grossi, F; Scolaro, T; Ardizzoni, A
      Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines

      LUNG CANCER
    7. Castagneto, B; Zai, S; Mutti, L; Lazzaro, A; Ridolfi, R; Piccolini, E; Ardizzoni, A; Fumagalli, L; Valsuani, G; Botta, M
      Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion - Results of a phase II study on 31 consecutive patients

      LUNG CANCER
    8. Ardizzoni, A; Cafferata, MA; Paganuzzi, M; Filiberti, R; Marroni, P; Neri, M; Fontana, V; Nicolo, G; Perdelli, L; Stampino, CG; Rosso, R; Puntoni, R
      Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

      CANCER
    9. Parra, HS; Tixi, L; Latteri, F; Bretti, S; Alloisio, M; Gravina, A; Lionetto, R; Bruzzi, P; Dani, C; Rosso, R; Cosso, M; Balzarini, L; Santoro, A; Ardizzoni, A
      Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)

      CANCER
    10. Ardizzoni, A; Grossi, F; Salvati, F; Silvano, G; Santi, L
      Managing patients with lung cancer - Common international guidelines must be developed

      BRITISH MEDICAL JOURNAL
    11. Ardizzoni, A; Grossi, F
      Update on the treatment of small cell lung cancer (SCLC)

      ANNALS OF ONCOLOGY
    12. Ardizzoni, A; Antonelli, G; Ricci, S; Frasci, G; Rinaldi, M; Boni, L; Galletti, P; Pennucci, MC; Antonuzzo, A; Gravina, A; Galli, L; Comella, G; Conte, PF; Salvati, F; Rosso, R
      Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    13. Ardizzoni, A; Grossi, F; Meazza, R; Ferrini, S
      New perspectives for the pharmacological and biological therapy of small cell lung cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    14. Loprevite, M; Favoni, RE; de Cupis, A; Pirani, P; Merlo, F; Grossi, F; Ardizzoni, A
      Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity

      INTERNATIONAL JOURNAL OF ONCOLOGY
    15. Ardizzoni, A; Antonelli, G; Grossi, F; Tixi, L; Cafferata, M; Rosso, R
      The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC)

      ANNALS OF ONCOLOGY
    16. Orengo, AM; Procopio, A; Favoni, RE; De Cupis, A; Ardizzoni, A; Castagneto, B; Ribotta, M; Detta, PG; Ferrini, S; Mutti, L
      Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis

      EUROPEAN RESPIRATORY JOURNAL
    17. De Marinis, F; Rinaldi, M; Ardizzoni, A; Bruzzi, P; Pennucci, MC; Portalone, L; D'Aprile, M; Ripanti, P; Romano, F; Belli, M; Altavilla, G; Migliorino, MR; Rosso, R; Salvati, F
      The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: A phase III randomized FONICAP trial

      TUMORI
    18. van Meerbeeck, JP; Bass, P; Debruyne, C; Groen, HJ; Manegold, C; Ardizzoni, A; Gridelli, C; van Marck, EA; Lentz, M; Giaccone, G
      A phase II study of gemcitabine in patients with malignant pleural mesothelioma

      CANCER
    19. Ardizzoni, A; Grossi, F; Scolaro, T; Giudici, S; Foppiano, F; Boni, L; Tixi, L; Cosso, M; Mereu, C; Ratto, GB; Vitale, V; Rosso, R
      Induction chemotherapy followed by concurrent standard radiotherapy and daily low dose cisplatin in locally advanced non-small-cell lung cancer

      BRITISH JOURNAL OF CANCER
    20. ARDIZZONI A; TIXI L; ROSSO R
      NSCLC IN THE ELDERLY, GEMCITABINE - A STEP BEYOND

      Annals of oncology
    21. Ardizzoni, A; Cafferata, MA; Rosso, R
      Epoetin-alpha in lung tumors

      TUMORI
    22. GROSSI F; PENNUCCI MC; TIXI L; CAFFERATA MA; ARDIZZONI A
      MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS

      Drugs
    23. BALDINI E; TIBALDI C; ARDIZZONI A; SALVATI F; ANTILLI A; PORTALONE L; BARBERA S; ROMANO F; DEMARINIS F; MIGLIORINO MR; NOSEDA MA; BORGHINI U; CRIPPA M; FERRARA G; RAIMONDI M; FIORETTI M; BANDERA M; PENNUCCI MC; GALEASSO G; CACCIANI GC; LEPIDINI G; SUNSERI G; LANFRANCO C; RINALDI M; LIONETTO R; CONTE PF; ROSSO R
      CISPLATIN-VINDESINE-MITOMYCIN (MVP) VS CISPLATIN-IFOSFAMIDE-VINORELBINE (PIN) VS CARBOPLATIN-VINORELBINE (CAN) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A FONICAP RANDOMIZED PHASE-II STUDY

      British Journal of Cancer
    24. LOPREVITE M; VARESCO L; FAVONI R; FERRARA GB; MORO F; OTTAGGIO L; FRONZA G; CAMPOMENOSI P; ABBONDANDOLO A; CUTRONA G; RONCELLA S; ALBINI A; ALUIGI MG; POZZI S; PERA C; BITICCHI R; GISMONDI V; GROSSI F; PENNUCCI MC; ARDIZZONI A
      ANALYSIS OF K-RAS, P53, BCL-2 AND RB EXPRESSION IN NONSMALL CELL LUNG-CANCER CELL-LINES

      International journal of oncology
    25. TRAVERSARI C; MEAZZA R; COPPOLECCHIA M; BASSO S; VERRECCHIA A; VANDERBRUGGEN P; ARDIZZONI A; GAGGERO A; FERRINI S
      IFN-GAMMA GENE-TRANSFER RESTORES HLA-CLASS-I EXPRESSION AND MAGE-3 ANTIGEN PRESENTATION TO CTL IN HLA-DEFICIENT SMALL-CELL LUNG-CANCER

      Gene therapy
    26. SAHMOUD T; POSTMUS PE; VANPOTTELSBERGHE C; MATTSON K; TAMMILEHTO L; SPLINTER TAW; PLANTING AST; SUTEDJA T; VANPAWEL J; VANZANDWIJK N; BAAS P; ROOZENDAAL KJ; SCHRIJVER M; KIRKPATRICK A; VANGLABBEKE M; ARDIZZONI A; GIACCONE G
      ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP

      European journal of cancer
    27. VANZANDWIJK N; GROEN HJM; POSTMUS PE; BURGHOUTS JTW; TENVELDE GPM; ARDIZZONI A; SMITH IE; BAAS P; SAHMOUD T; KIRKPATRICK A; DALESIO O; GIACCONE G
      ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP

      European journal of cancer
    28. ECKARDT J; DEPIERRE A; ARDIZZONI A; VONPAWEL J; FIELDS S
      POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC)

      European journal of cancer
    29. ARDIZZONI A; HANSEN H; DOMBERNOWSKY P; GAMUCCI T; KAPLAN S; POSTMUS P; GIACCONE G; SCHAEFER B; WANDERS J; VERWEIJ J
      TOPOTECAN, A NEW ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY IN PATIENTS WITH REFRACTORY AND SENSITIVE DISEASE

      Journal of clinical oncology
    30. MARTIN C; ARDIZZONI A; ROSSO R
      GEMCITABINE - SAFETY PROFILE AND EFFICACY IN NONSMALL CELL LUNG-CANCER UNAFFECTED BY AGE

      Aging
    31. SCOLARO T; ARDIZZONI A; GIUDICI S; GROSSI F; COSSO M; PENNUCCI MC; BACIGALUPO A; ROSSO R; VITALE V
      PHASE-II STUDY OF INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY COMBINED WITH DAILY CISPLATIN IN STAGE-III INOPERABLE NONSMALL CELL LUNG-CANCER (NSCLC)

      International journal of radiation oncology, biology, physics
    32. SALVIOLI S; ARDIZZONI A; FRANCESCHI C; COSSARIZZA A
      JC-1, BUT NOT DIOC(6)(3) OR RHODAMINE-123, IS A RELIABLE FLUORESCENT-PROBE TO ASSESS DELTA-PSI CHANGES IN INTACT-CELLS - IMPLICATIONS FOR STUDIES ON MITOCHONDRIAL FUNCTIONALITY DURING APOPTOSIS

      FEBS letters
    33. BERTELLI G; CAFFERATA MA; ARDIZZONI A; GOZZA A; ROSSO R; DINI D
      SKIN ULCERATION POTENTIAL OF PACLITAXEL IN A MOUSE SKIN MODEL IN-VIVO

      Cancer
    34. PENNUCCI MC; ARDIZZONI A; PRONZATO P; FIORETTI M; LANFRANCO C; VERNA A; GIORGI G; VIGANI A; FROLA C; ROSSO R
      COMBINED CISPLATIN, DOXORUBICIN, AND MITOMYCIN FOR THE TREATMENT OF ADVANCED PLEURAL MESOTHELIOMA - A PHASE-II FONICAP TRIAL

      Cancer
    35. DECUPIS A; CIOMEI M; PIRANI P; FERRERA A; ARDIZZONI A; FAVONI RE
      ANTI-INSULIN-LIKE GROWTH-FACTOR-I ACTIVITY OF A NOVEL POLYSULPHONATEDDISTAMYCIN-A DERIVATIVE IN HUMAN LUNG-CANCER CELL-LINES

      British Journal of Pharmacology
    36. FASSINA G; PAGLIALUNGA G; FONTANINI G; COSIMI A; PERROTTA A; ALUIGI MG; ARDIZZONI A; ALBINI A
      EXPRESSION OF MESSENGER-RNA FOR GELATINASE-A AND TIMP-2 IN CELL-CULTURES AND TISSUE SAMPLES DERIVED FROM BREAST AND LUNG CARCINOMAS

      International journal of oncology
    37. GIACCONE G; ARDIZZONI A; KIRKPATRICK A; CLERICO M; SAHMOUD T; VANZANDWIJK N
      CISPLATIN AND ETOPOSIDE COMBINATION CHEMOTHERAPY FOR LOCALLY ADVANCEDOR METASTATIC THYMOMA - A PHASE-II STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP

      Journal of clinical oncology
    38. VENTURINI M; DELMASTRO L; TESTORE F; DANOVA M; GARRONE O; LANFRANCO C; LATINI F; SERTOLI MR; LIONETTO R; QUEIROLO P; ARDIZZONI A; ROSSO R
      ERYTHROPOIETIN AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FASTER ALLOW ACCELERATION AND DOSE-ESCALATION OF CYCLOPHOSPHAMIDE EPIDOXORUBICIN/5 FLUOROURACIL CHEMOTHERAPY - A DOSE-FINDING STUDY IN PATIENTS WITHADVANCED BREAST-CANCER/

      Cancer chemotherapy and pharmacology
    39. ARDIZZONI A
      EFFICIENT DESIGNS FOR TESTING NEW AGENTS AND REGIMENS

      Chest
    40. ARDIZZONI A; PENNUCCI MC; DANOVA M; VISCOLI C; MARIANI GL; GIORGI G; VENTURINI M; MEREU C; SCOLARO T; ROSSO R
      PHASE-I STUDY OF SIMULTANEOUS DOSE-ESCALATION AND SCHEDULE ACCELERATION OF CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE USING GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT ANTIMICROBIAL PROPHYLAXIS IN PATIENTS WITH SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    41. MEAZZA R; MARCIANO S; SFORZINI S; ORENGO AM; COPPOLECCHIA M; MUSIANI P; ARDIZZONI A; SANTI L; AZZARONE B; FERRINI S
      ANALYSIS OF IL-2 RECEPTOR EXPRESSION AND OF THE BIOLOGICAL EFFECTS OFIL-2 GENE TRANSFECTION IN SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    42. ARDIZZONI A; HANSEN HH; DOMBERNOWSKY P; KAPLAN S; POSTMUS PE; GAMUCCI T; SCHAEFER B; WANDERS J; VERWEIJ J
      PHASE-II STUDY OF TOPOTECAN IN REFRACTORY AND SENSITIVE SMALL-CELL LUNG-CANCER (SCLC)

      European journal of cancer
    43. BALDINI E; PORTALONE L; DEMARINIS F; BARBERA S; ARDIZZONI A; PENNUCCI MC; RAIMONDI M; CONTE PF; SALVATI F; CAFFERATA MA; SORESI E; PORCILE GF; TESTORE F; RIMOLDI R; BANDERA M; DIROSA T; RINALDI M; LIONETTO R; ROSSO R
      CISPLATIN, VINDESINE, MITOMYCIN (MVP) VS CISPLATIN, IFOSFAMIDE, NAVELBINE (PIN) VS CARBOPLATIN, NAVELBINE (CAN) IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)

      European journal of cancer
    44. MEAZZA R; MARCIANO S; COPPOLECCHIA M; BIASSANI R; SFORZINI S; ORENGO AM; ARDIZZONI A; AZZARONE B; FERRINI S
      BIOLOGICAL CHARACTERISTICS OF SMALL-CELL LUNG-CANCER (SCLC) CELLS TRANSFECTED WITH HUMAN IL-2 GENE

      European journal of cancer
    45. POSTMUS PE; SMIT EF; HAAXMAREICHE H; VANZANDWIJK N; ARDIZZONI A; QUOIX E; KIRKPATRICK A; SAHMOUD T; GIACCONE G
      TENIPOSIDE FOR BRAIN METASTASES OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY

      Journal of clinical oncology
    46. ARDIZZONI A
      CAMPTOTHECIN ANALOGS IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER

      Lung cancer
    47. ARDIZZONI A; ADDAMO GF; BALDINI E; BORGHINI U; PORTALONE L; DEMARINIS F; LIONETTO R; CONTE PF; BRUZZI P; PENNUCCI MC; VENTURINI M; RINALDI M; ROSSO R; SALVATI F
      MITOMYCIN-IFOSFAMIDE-CISPLATINUM (MIP) VS MIP-INTERFERON VS CISPLATINUM-CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A FONICAP RANDOMIZED PHASE-II STUDY

      British Journal of Cancer
    48. ARDIZZONI A; PENNUCCI MC; CASTAGNETO B; MARIANI GL; CINQUEGRANA A; MAGRI D; VERNA A; SALVATI F; ROSSO R
      RECOMBINANT INTERFERON-ALPHA-2B IN THE TREATMENT OF DIFFUSE MALIGNANTPLEURAL MESOTHELIOMA

      American journal of clinical oncology
    49. GREEN MR; GINSBERG R; ARDIZZONI A; CHOI N; DARWISH S; FUKUOKA M; GINER V; GRUNENWALD D; HARPER P; KHO S; LECHEVALIER T; LEWINSKI T; PAYNE D; POSTMUS P; ROCMANS P; ROSELL R; ROTH J; SCULIER JP; SORENSEN JB
      INDUCTION THERAPY FOR STAGE-III NSCLC - A CONSENSUS REPORT

      Lung cancer
    50. GREEN MR; COX JD; ARDIZZONI A; ARRIAGADA R; BUREAU G; DARWISH S; DENEFFE G; FUKUOKA M; JOSEPH D; KOMAKI R; MIRIMANOFF RO; MORNEX F; PALAZZI M; PASTORINO U; PAVY JJ; POSTMUS PE; ROTH J; RUBIN P; SAIJO N; SAUNDERS M; STOUT R; SUTEDJA TG; TROVO MG
      END-POINTS FOR MULTIMODAL CLINICAL-TRIALS IN STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC) - A CONSENSUS REPORT

      Lung cancer
    51. FAVONI RE; DECUPIS A; RAVERA F; CANTONI C; PIRANI P; ARDIZZONI A; NOONAN D; BIASSONI R
      EXPRESSION AND FUNCTION OF THE INSULIN-LIKE GROWTH-FACTOR-I SYSTEM INHUMAN NON-SMALL-CELL LUNG-CANCER AND NORMAL LUNG-CELL LINES

      International journal of cancer
    52. FAVONI RE; RAVERA F; PIRANI P; ARDIZZONI A; NOONAN D; DECUPIS A
      SURAMIN INTERFERES WITH AUTO PARACRINE INSULIN-LIKE GROWTH-FACTOR I-CONTROLLED PROLIFERATIVE LOOP ON HUMAN LUNG-CANCER CELL-LINES/

      European journal of pharmacology
    53. FAVONI RE; RAVERA F; PIRANI P; ARDIZZONI A; NOONAN D; DECUPIS A
      SURAMIN INTERFERES WITH AUTO PARACRINE INSULIN-LIKE GROWTH-FACTOR I-CONTROLLED PROLIFERATIVE LOOP ON HUMAN LUNG-CANCER CELL-LINES/

      European journal of pharmacology
    54. ARDIZZONI A; BONAVIA M; VIALE M; BALDINI E; MEREU C; VERNA A; FERRINI S; CINQUEGRANA A; MOLINARI S; MARIANI GL; ROEST GJ; SHARENBERG J; PALMER PA; ROSSO R; ROPOLO F; RASO C
      BIOLOGIC AND CLINICAL EFFECTS OF CONTINUOUS-INFUSION INTERLEUKIN-2 INPATIENTS WITH NONSMALL CELL LUNG-CANCER

      Cancer
    55. ARDIZZONI A; VENTURINI M; SERTOLI MR; GIANNESSI PG; BREMA F; DANOVA M; TESTORE F; MARIANI GL; PENNUCCI MC; QUEIROLO P; SILVESTRO S; BRUZZI P; LIONETTO R; LATINI F; ROSSO R
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ALLOWS ACCELERATION AND DOSE INTENSITY INCREASE OF CEF CHEMOTHERAPY - A RANDOMIZED STUDY IN PATIENTS WITH ADVANCED BREAST-CANCER

      British Journal of Cancer
    56. JASSEM J; KARNICKAMLODKOWSKA H; VANPOTTELSBERGHE C; VANGLABBEKE M; NOSEDA MA; ARDIZZONI A; GOZZELINO F; PLANTING A; VANZANDWIJK N
      PHASE-II STUDY OF VINORELBINE (NAVELBINE) IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER PATIENTS

      European journal of cancer
    57. FUSCO V; ARDIZZONI A; MERLO F; CINQUEGRANA A; FARAVELLI B; DEPALMA M; CHESSA L; NICOLO G; SERRA M; CAPACCIO A; ROSSO R
      MALIGNANT PLEURAL MESOTHELIOMA - MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS ON 113 PATIENTS

      Anticancer research
    58. ARDIZZONI A; SALVATI F; ROSSO R; BRUZZI P; RUBAGOTTI A; PENNUCCI MC; MARIANI GL; DEMARINIS F; PALLOTTA G; ANTILLI A; CRUCIANI AM; RINALDI M; TONACHELLA R; FIORETTI M; BARBERA S; MANTELLINI E; SORESI E; PASTORINO G; BELLI M; FERRARA G; VENTURINI M; SCAGLIOTTI G; SANTI L; PORTALONE L; CRIPPA M; BORGHINI U; BREMA F; RIMOLDI R; BANDERA M; PIACENZA G; ROMANO F; COLANTUONI G; BONSIGNORE G; EPIS R; ANDREOLA E; SCAGLIOTTI E; POZZI E; BOTTA M; CASTAGNETO B; LANFRANCO C; TESTORE F; LUPPIS B; DEPALMA M; ROCCHI D; BARACCO F; CINQUEGRANA A; RASO C; BONAVIA M; ROPOLO F
      COMBINATION OF CHEMOTHERAPY AND RECOMBINANT ALPHA-INTERFERON IN ADVANCED NONSMALL CELL LUNG-CANCER - MULTICENTRIC RANDOMIZED FONICAP TRIAL REPORT

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 15:22:54